Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2009-08-21
- Last Posted Date
- 2009-09-09
- Lead Sponsor
- NeoPlas Innovation
- Target Recruit Count
- 250
- Registration Number
- NCT00963664
- Locations
- 🇺🇸
NeoPlas Innovation, Nashville, Tennessee, United States
© Copyright 2024. All Rights Reserved by MedPath